
TSE:MFC
This summary was created by AI, based on 28 opinions in the last 12 months.
Manulife Financial (MFC) has received mixed reviews from experts, highlighting its strengths in capital management, particularly in Asia and wealth management. Several analysts view it as a reliable income stock, benefiting from a decent dividend yield, yet caution against its growth potential compared to Canadian banks. The company has faced short-term challenges, including mixed results from its alternative portfolio and limited growth in its U.S. operations, which has sparked some concerns. Analysts suggest waiting for opportunities to buy during pullbacks, given its valuation relative to major financials, alongside the potential for increased profitability stemming from rising interest rates. Overall, while MFC is generally recognized for its stability and improvements in earnings quality, it struggles to capture investor attention amidst recent market shifts.
Good, solid, big Canadian financial. Has had a great run over the last year. Just had a weak quarter so in the short term he expects a little bit of weakness. Good, solid, blue chip company. Most of the damage was done 5 years ago in the 2008-2009 pull back. Could see a bit of a pull back this summer.
This company is still a little bit levered to the market, so if you believe the market is going up, you step into this. If you don’t, then you go to another insurer. Has done quite well but recently broke its upward trend line and is going sideways. Major support is about $13 and if it breaks that support on the downside, it would then go down to about $12.50. If you own, you might want to hold it a little bit but this is not the seasonal time for this company.
Rising interest rates are good for insurance companies, falling equity markets are bad for them. Doesn’t think there is a material downturn (i.e. ~20%) in the next year, though.